Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| QUAKER CHEMICAL CORPKWR · Entity 4278 | Director · CEO and President | March 15, 2026 | March 17, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
QUAKER CHEMICAL CORP
Report date March 15, 2026 · Filed March 17, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 15,393 |
Ending reported balance
After 2026-03-15 transaction · row 6
6 source rows · reconciled sequenceRow 1 · 2026-03-15 · Grant · Acquired 1,396 · Balance 13,639 F1: Shares earned upon vesting and settlement of Performance Stock Units (PSUs) awarded on March 15, 2023, upon certification of performance results by the Compensation and Human Resources Committee based on achievement of the adjusted return on invested capital (ROIC) metric, during the three year performance period. Row 2 · 2026-03-15 · Exercise / conversion · Acquired 466 · Balance 14,105 F2: Restricted stock units (RSUs) convert into common stock on a one-for-one basis. Row 3 · 2026-03-15 · Exercise / conversion · Acquired 462 · Balance 14,567 F2: Restricted stock units (RSUs) convert into common stock on a one-for-one basis. Row 4 · 2026-03-15 · Exercise / conversion · Acquired 2,387 · Balance 16,954 F2: Restricted stock units (RSUs) convert into common stock on a one-for-one basis. Row 5 · 2026-03-15 · Exercise / conversion · Acquired 62 · Balance 17,016 F3: Dividend equivalent rights (DERs) accrued on reporting person's RSUs granted on March 15, 2024 (two grants) and March 15, 2025. The rights accrued when and as dividends were paid on KWR common stock. This Form 4 reports the settlement of DERs in connection with the second installment of the 2024 RSU grants and the first installment of the 2025 RSU grant, each vesting on March 15, 2026. Each DER was the economic equivalent of one share of KWR common stock. Row 6 · 2026-03-15 · Tax withholding · Disposed 1,623 · Balance 15,393 F4: Shares surrendered by reporting person to satisfy withholding tax obligations upon the full or partial vesting of certain restricted stock, PSUs, and RSUs previously granted under the Company's Long-Term Performance Incentive Plan. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 466 |
Reported balance
After 2026-03-15 transaction · row 8
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 8 · 2026-03-15 · Exercise / conversion · Disposed 466 · Balance 466 F2: Restricted stock units (RSUs) convert into common stock on a one-for-one basis. F6: On March 15, 2024, the reporting person was granted 1,398 time-based RSUs and 1,386 special time-based RSUs, with both awards vesting in three equal installments beginning on March 15, 2025. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 462 |
Reported balance
After 2026-03-15 transaction · row 9
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 9 · 2026-03-15 · Exercise / conversion · Disposed 462 · Balance 462 F2: Restricted stock units (RSUs) convert into common stock on a one-for-one basis. F6: On March 15, 2024, the reporting person was granted 1,398 time-based RSUs and 1,386 special time-based RSUs, with both awards vesting in three equal installments beginning on March 15, 2025. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 4,774 |
Reported balance
After 2026-03-15 transaction · row 10
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 10 · 2026-03-15 · Exercise / conversion · Disposed 2,387 · Balance 4,774 F2: Restricted stock units (RSUs) convert into common stock on a one-for-one basis. F7: On March 15, 2025, the reporting person was granted 7,161 time-based RSUs, vesting in three annual installments beginning on March 15, 2026. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 11,143 |
Reported balance
After 2026-03-15 transaction · row 12
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 12 · 2026-03-15 · Grant · Acquired 11,143 · Balance 11,143 F8: Time-based RSUs granted under the Company's Long-Term Performance Incentive Plan, which will vest in three annual installments beginning on March 15, 2027. Each RSU represents a contingent right to receive one share of KWR common stock and DERs accrue with respect to these RSUs when and as dividends are paid on KWR common stock. |
| Dividend Equivalent RightsSEC Table II · derivative / convertible security · Expires 2026-03-15 | Direct | 0 |
Reported balance
After 2026-03-15 transaction · row 11
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 11 · 2026-03-15 · Exercise / conversion · Disposed 62 · Balance 0 F3: Dividend equivalent rights (DERs) accrued on reporting person's RSUs granted on March 15, 2024 (two grants) and March 15, 2025. The rights accrued when and as dividends were paid on KWR common stock. This Form 4 reports the settlement of DERs in connection with the second installment of the 2024 RSU grants and the first installment of the 2025 RSU grant, each vesting on March 15, 2026. Each DER was the economic equivalent of one share of KWR common stock. |
| Common StockSEC Table I · non-derivative | IndirectBy 401(k) | 274 |
Reported balance
Holding disclosure · report date 2026-03-15 · row 7
Holding and transaction disclosures are not merged.
1 source rowRow 7 · Balance 274 F5: Information based on reporting person's Plan Statement as of December 31, 2025. |
Filing footnotes · ownership attribution and instrument terms
F1: Shares earned upon vesting and settlement of Performance Stock Units (PSUs) awarded on March 15, 2023, upon certification of performance results by the Compensation and Human Resources Committee based on achievement of the adjusted return on invested capital (ROIC) metric, during the three year performance period.
F2: Restricted stock units (RSUs) convert into common stock on a one-for-one basis.
F3: Dividend equivalent rights (DERs) accrued on reporting person's RSUs granted on March 15, 2024 (two grants) and March 15, 2025. The rights accrued when and as dividends were paid on KWR common stock. This Form 4 reports the settlement of DERs in connection with the second installment of the 2024 RSU grants and the first installment of the 2025 RSU grant, each vesting on March 15, 2026. Each DER was the economic equivalent of one share of KWR common stock.
F4: Shares surrendered by reporting person to satisfy withholding tax obligations upon the full or partial vesting of certain restricted stock, PSUs, and RSUs previously granted under the Company's Long-Term Performance Incentive Plan.
F5: Information based on reporting person's Plan Statement as of December 31, 2025.
F6: On March 15, 2024, the reporting person was granted 1,398 time-based RSUs and 1,386 special time-based RSUs, with both awards vesting in three equal installments beginning on March 15, 2025.
F7: On March 15, 2025, the reporting person was granted 7,161 time-based RSUs, vesting in three annual installments beginning on March 15, 2026.
F8: Time-based RSUs granted under the Company's Long-Term Performance Incentive Plan, which will vest in three annual installments beginning on March 15, 2027. Each RSU represents a contingent right to receive one share of KWR common stock and DERs accrue with respect to these RSUs when and as dividends are paid on KWR common stock.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| August 10, 2021 Filed Aug 12, 2021 20:23 UTC | QUAKER CHEMICAL CORP KWR · Entity 4278 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 923 | $0.00 Strike: $136.64 | $0.00 |
DisclosureSEC source: 0001209191-21-051099 · doc4.xml · derivative · entry 10 BERQUIST JOSEPH A · CIK 0001487224 · SVP, GL SPEC BUS & CSO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,844 Underlying: Common Stock · 923 shares Expires 2027-03-30 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: The options for this grant vest in three annual installments: 923 shares on March 30, 2021; 922 shares on March 30, 2022; and 922 shares on March 30, 2023. Read SEC document |
| August 10, 2021 Filed Aug 12, 2021 20:23 UTC | QUAKER CHEMICAL CORP KWR · Entity 4278 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 1,684 | $0.00 Strike: $154.92 | $0.00 |
DisclosureSEC source: 0001209191-21-051099 · doc4.xml · derivative · entry 9 BERQUIST JOSEPH A · CIK 0001487224 · SVP, GL SPEC BUS & CSO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 842 Underlying: Common Stock · 1,684 shares Expires 2026-02-25 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The options for this grant vest in three annual installments: 842 shares on February 25, 2020; 842 shares on February 25, 2021; and 842 shares on February 25, 2022. Read SEC document |
| August 10, 2021 Filed Aug 12, 2021 20:23 UTC | QUAKER CHEMICAL CORP KWR · Entity 4278 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 830 | $0.00 Strike: $151.75 | $0.00 |
DisclosureSEC source: 0001209191-21-051099 · doc4.xml · derivative · entry 8 BERQUIST JOSEPH A · CIK 0001487224 · SVP, GL SPEC BUS & CSO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 830 shares Expires 2025-02-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The options for this grant vested in three annual installments: 830 shares on February 26, 2019; 830 shares on February 26, 2020; and 830 shares on February 26, 2021. Read SEC document |
| August 10, 2021 Filed Aug 12, 2021 20:23 UTC | QUAKER CHEMICAL CORP KWR · Entity 4278 | SaleCommon Stock | 923 | $256.00 | $236,288.00 |
DisclosureSEC source: 0001209191-21-051099 · doc4.xml · nonDerivative · entry 6 BERQUIST JOSEPH A · CIK 0001487224 · SVP, GL SPEC BUS & CSO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,688 Read SEC document |
| August 10, 2021 Filed Aug 12, 2021 20:23 UTC | QUAKER CHEMICAL CORP KWR · Entity 4278 | Exercise / conversionCommon Stock | 923 | $136.64 | $126,118.72 |
DisclosureSEC source: 0001209191-21-051099 · doc4.xml · nonDerivative · entry 5 BERQUIST JOSEPH A · CIK 0001487224 · SVP, GL SPEC BUS & CSO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,611 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 10, 2021 Filed Aug 12, 2021 20:23 UTC | QUAKER CHEMICAL CORP KWR · Entity 4278 | SaleCommon Stock | 1,684 | $256.00 | $431,104.00 |
DisclosureSEC source: 0001209191-21-051099 · doc4.xml · nonDerivative · entry 4 BERQUIST JOSEPH A · CIK 0001487224 · SVP, GL SPEC BUS & CSO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,688 Read SEC document |
| August 10, 2021 Filed Aug 12, 2021 20:23 UTC | QUAKER CHEMICAL CORP KWR · Entity 4278 | Exercise / conversionCommon Stock | 1,684 | $154.92 | $260,885.28 |
DisclosureSEC source: 0001209191-21-051099 · doc4.xml · nonDerivative · entry 3 BERQUIST JOSEPH A · CIK 0001487224 · SVP, GL SPEC BUS & CSO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,372 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 10, 2021 Filed Aug 12, 2021 20:23 UTC | QUAKER CHEMICAL CORP KWR · Entity 4278 | SaleCommon Stock | 830 | $256.00 | $212,480.00 |
DisclosureSEC source: 0001209191-21-051099 · doc4.xml · nonDerivative · entry 2 BERQUIST JOSEPH A · CIK 0001487224 · SVP, GL SPEC BUS & CSO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,688 Read SEC document |
| August 10, 2021 Filed Aug 12, 2021 20:23 UTC | QUAKER CHEMICAL CORP KWR · Entity 4278 | Exercise / conversionCommon Stock | 830 | $151.75 | $125,952.50 |
DisclosureSEC source: 0001209191-21-051099 · doc4.xml · nonDerivative · entry 1 BERQUIST JOSEPH A · CIK 0001487224 · SVP, GL SPEC BUS & CSO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,518 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 15, 2021 Filed Mar 17, 2021 20:22 UTC | QUAKER CHEMICAL CORP KWR · Entity 4278 | GrantEmployee Stock Option (right to buy) · Derivative | 1,319 | $0.00 Strike: $245.49 | $0.00 |
DisclosureSEC source: 0001209191-21-021329 · doc4.xml · derivative · entry 3 BERQUIST JOSEPH A · CIK 0001487224 · SVP, GL SPEC BUS & CSO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,319 Underlying: Common Stock · 1,319 shares Expires 2028-03-15 F1 · derivative.exercise_date: This award represents time-based restricted stock and stock options granted to reporting person for the 2021-2023 Performance Period under the Company's 2016 Long-Term Performance Incentive Plan. The restricted stock vests on March 15, 2024 and the stock options are exercisable in three consecutive annual installments: 439 shares on March 15, 2022; 440 shares on March 15, 2023; and 440 shares on March 15, 2024. Read SEC document |
| March 15, 2021 Filed Mar 17, 2021 20:22 UTC | QUAKER CHEMICAL CORP KWR · Entity 4278 | GrantCommon Stock | 367 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-021329 · doc4.xml · nonDerivative · entry 1 BERQUIST JOSEPH A · CIK 0001487224 · SVP, GL SPEC BUS & CSO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,688 F1 · shares: This award represents time-based restricted stock and stock options granted to reporting person for the 2021-2023 Performance Period under the Company's 2016 Long-Term Performance Incentive Plan. The restricted stock vests on March 15, 2024 and the stock options are exercisable in three consecutive annual installments: 439 shares on March 15, 2022; 440 shares on March 15, 2023; and 440 shares on March 15, 2024. Read SEC document |
| February 26, 2021 Filed Mar 2, 2021 21:12 UTC | QUAKER CHEMICAL CORP KWR · Entity 4278 | Tax withholdingCommon Stock | 194 | $282.38 | $54,781.72 |
DisclosureSEC source: 0001209191-21-015865 · doc4.xml · nonDerivative · entry 1 BERQUIST JOSEPH A · CIK 0001487224 · SVP, GL SPEC BUS & CSO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,321 F1 · shares: Shares surrendered by reporting person to satisfy withholding tax obligation upon vesting of restricted stock granted on February 26, 2018 under the Company's 2016 Long-Term Performance Incentive Plan. Read SEC document |
| November 12, 2020 Filed Nov 16, 2020 21:21 UTC | QUAKER CHEMICAL CORP KWR · Entity 4278 | OtherCommon Stock | 1,400 | $239.77 | $335,678.00 |
DisclosureSEC source: 0001209191-20-058466 · doc4.xml · nonDerivative · entry 1 BERQUIST JOSEPH A · CIK 0001487224 · SVP, GL SPEC BUS & CSO 10b5-1 filing: Not disclosed Ownership: Indirect · By 401(k) Disclosed balance after: 201 F1 · balance_after: Based on account information as of November 12, 2020 and obtained by reporting person from Plan Administrator. Read SEC document |
| August 11, 2020 Filed Aug 12, 2020 20:30 UTC | QUAKER CHEMICAL CORP KWR · Entity 4278 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 1,660 | $0.00 Strike: $151.75 | $0.00 |
DisclosureSEC source: 0001209191-20-046372 · doc4.xml · derivative · entry 9 BERQUIST JOSEPH A · CIK 0001487224 · SVP, GL SPEC BUS & CSO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 830 Underlying: Common Stock · 1,660 shares Expires 2025-02-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · derivative.exercise_date: The options for this grant vest in three annual installments: 830 shares on February 26, 2019; 830 shares on February 26, 2020; and 830 shares on February 26, 2021. Read SEC document |
| August 11, 2020 Filed Aug 12, 2020 20:30 UTC | QUAKER CHEMICAL CORP KWR · Entity 4278 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 2,188 | $0.00 Strike: $134.60 | $0.00 |
DisclosureSEC source: 0001209191-20-046372 · doc4.xml · derivative · entry 8 BERQUIST JOSEPH A · CIK 0001487224 · SVP, GL SPEC BUS & CSO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,188 shares Expires 2024-02-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_date: The options for this grant vested in three annual installments: 730 shares on February 27, 2018; 729 shares on February 27, 2019; and 729 shares on February 27, 2020. Read SEC document |
| August 11, 2020 Filed Aug 12, 2020 20:30 UTC | QUAKER CHEMICAL CORP KWR · Entity 4278 | SaleCommon Stock | 472 | $202.68 | $95,664.96 |
DisclosureSEC source: 0001209191-20-046372 · doc4.xml · nonDerivative · entry 6 BERQUIST JOSEPH A · CIK 0001487224 · SVP, GL SPEC BUS & CSO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,515 F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $202.41 to $203.085, inclusive. The reporting person undertakes to provide to Quaker Chemical Corporation, d/b/a "Quaker Houghton", any security holder of Quaker Houghton, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (4) to this Form 4. Read SEC document |
| August 11, 2020 Filed Aug 12, 2020 20:30 UTC | QUAKER CHEMICAL CORP KWR · Entity 4278 | SaleCommon Stock | 1,188 | $201.75 | $239,679.00 |
DisclosureSEC source: 0001209191-20-046372 · doc4.xml · nonDerivative · entry 5 BERQUIST JOSEPH A · CIK 0001487224 · SVP, GL SPEC BUS & CSO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,987 F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $201.14 to $202.13, inclusive. The reporting person undertakes to provide to Quaker Chemical Corporation, d/b/a "Quaker Houghton", any security holder of Quaker Houghton, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (3) to this Form 4. Read SEC document |
| August 11, 2020 Filed Aug 12, 2020 20:30 UTC | QUAKER CHEMICAL CORP KWR · Entity 4278 | Exercise / conversionCommon Stock | 1,660 | $151.75 | $251,905.00 |
DisclosureSEC source: 0001209191-20-046372 · doc4.xml · nonDerivative · entry 4 BERQUIST JOSEPH A · CIK 0001487224 · SVP, GL SPEC BUS & CSO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,175 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 11, 2020 Filed Aug 12, 2020 20:30 UTC | QUAKER CHEMICAL CORP KWR · Entity 4278 | SaleCommon Stock | 200 | $202.61 | $40,522.00 |
DisclosureSEC source: 0001209191-20-046372 · doc4.xml · nonDerivative · entry 3 BERQUIST JOSEPH A · CIK 0001487224 · SVP, GL SPEC BUS & CSO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,515 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $202.575 to $202.635, inclusive. The reporting person undertakes to provide to Quaker Chemical Corporation, d/b/a "Quaker Houghton", any security holder of Quaker Houghton, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4. Read SEC document |
| August 11, 2020 Filed Aug 12, 2020 20:30 UTC | QUAKER CHEMICAL CORP KWR · Entity 4278 | SaleCommon Stock | 1,988 | $201.97 | $401,516.36 |
DisclosureSEC source: 0001209191-20-046372 · doc4.xml · nonDerivative · entry 2 BERQUIST JOSEPH A · CIK 0001487224 · SVP, GL SPEC BUS & CSO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,715 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $201.42 to $202.41, inclusive. The reporting person undertakes to provide to Quaker Chemical Corporation, d/b/a "Quaker Houghton", any security holder of Quaker Houghton, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) to this Form 4. Read SEC document |
| August 11, 2020 Filed Aug 12, 2020 20:30 UTC | QUAKER CHEMICAL CORP KWR · Entity 4278 | Exercise / conversionCommon Stock | 2,188 | $134.60 | $294,504.80 |
DisclosureSEC source: 0001209191-20-046372 · doc4.xml · nonDerivative · entry 1 BERQUIST JOSEPH A · CIK 0001487224 · SVP, GL SPEC BUS & CSO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,703 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 19, 2020 Filed May 20, 2020 20:41 UTC | QUAKER CHEMICAL CORP KWR · Entity 4278 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 1,213 | $0.00 Strike: $72.12 | $0.00 |
DisclosureSEC source: 0001209191-20-030899 · doc4.xml · derivative · entry 6 BERQUIST JOSEPH A · CIK 0001487224 · SVP, GL SPEC BUS & CSO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,213 shares Expires 2023-02-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: The options for this grant vested in three annual installments: 1,213 shares on February 23, 2017; 1,213 shares on February 23, 2018; and 1,213 shares on February 23, 2019. Read SEC document |
| May 19, 2020 Filed May 20, 2020 20:41 UTC | QUAKER CHEMICAL CORP KWR · Entity 4278 | SaleCommon Stock | 600 | $167.08 | $100,248.00 |
DisclosureSEC source: 0001209191-20-030899 · doc4.xml · nonDerivative · entry 4 BERQUIST JOSEPH A · CIK 0001487224 · SVP, GL SPEC BUS & CSO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,515 F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $166.65 to $167.46, inclusive. The reporting person undertakes to provide to Quaker Chemical Corporation, d/b/a "Quaker Houghton", any security holder of Quaker Houghton, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (3) to this Form 4. Read SEC document |
| May 19, 2020 Filed May 20, 2020 20:41 UTC | QUAKER CHEMICAL CORP KWR · Entity 4278 | SaleCommon Stock | 200 | $165.53 | $33,106.00 |
DisclosureSEC source: 0001209191-20-030899 · doc4.xml · nonDerivative · entry 3 BERQUIST JOSEPH A · CIK 0001487224 · SVP, GL SPEC BUS & CSO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,115 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $165.18 to $165.87, inclusive. The reporting person undertakes to provide to Quaker Chemical Corporation, d/b/a "Quaker Houghton", any security holder of Quaker Houghton, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4. Read SEC document |
| May 19, 2020 Filed May 20, 2020 20:41 UTC | QUAKER CHEMICAL CORP KWR · Entity 4278 | SaleCommon Stock | 413 | $164.75 | $68,041.75 |
DisclosureSEC source: 0001209191-20-030899 · doc4.xml · nonDerivative · entry 2 BERQUIST JOSEPH A · CIK 0001487224 · SVP, GL SPEC BUS & CSO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,315 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $164.15 to $165.00, inclusive. The reporting person undertakes to provide to Quaker Chemical Corporation, d/b/a "Quaker Houghton", any security holder of Quaker Houghton, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) to this Form 4. Read SEC document |
| May 19, 2020 Filed May 20, 2020 20:41 UTC | QUAKER CHEMICAL CORP KWR · Entity 4278 | Exercise / conversionCommon Stock | 1,213 | $72.12 | $87,481.56 |
DisclosureSEC source: 0001209191-20-030899 · doc4.xml · nonDerivative · entry 1 BERQUIST JOSEPH A · CIK 0001487224 · SVP, GL SPEC BUS & CSO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,728 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 30, 2020 Filed Apr 1, 2020 20:36 UTC | QUAKER CHEMICAL CORP KWR · Entity 4278 | GrantEmployee Stock Option (right to buy) · Derivative | 2,767 | $0.00 Strike: $136.64 | $0.00 |
DisclosureSEC source: 0001209191-20-022128 · doc4.xml · derivative · entry 3 BERQUIST JOSEPH A · CIK 0001487224 · SVP, GL SPEC BUS & CSO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,767 Underlying: Common Stock · 2,767 shares Expires 2027-03-30 F1 · derivative.exercise_date: This award represents time-based restricted stock and stock options granted to reporting person for the 2020-2022 Performance Period under the Company's 2016 Long-Term Performance Incentive Plan. The restricted stock vests on March 30, 2023 and the stock options are exercisable in three consecutive annual installments: 923 shares on March 30, 2021; 922 shares on March 30, 2022; and 922 shares on March 30, 2023. Read SEC document |
| March 30, 2020 Filed Apr 1, 2020 20:36 UTC | QUAKER CHEMICAL CORP KWR · Entity 4278 | GrantCommon Stock | 634 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-022128 · doc4.xml · nonDerivative · entry 1 BERQUIST JOSEPH A · CIK 0001487224 · SVP, GL SPEC BUS & CSO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,515 F1 · shares: This award represents time-based restricted stock and stock options granted to reporting person for the 2020-2022 Performance Period under the Company's 2016 Long-Term Performance Incentive Plan. The restricted stock vests on March 30, 2023 and the stock options are exercisable in three consecutive annual installments: 923 shares on March 30, 2021; 922 shares on March 30, 2022; and 922 shares on March 30, 2023. Read SEC document |
| February 27, 2020 Filed Mar 2, 2020 21:09 UTC | QUAKER CHEMICAL CORP KWR · Entity 4278 | Tax withholdingCommon Stock | 160 | $163.31 | $26,129.60 |
DisclosureSEC source: 0001209191-20-014418 · doc4.xml · nonDerivative · entry 1 BERQUIST JOSEPH A · CIK 0001487224 · SVP, GL SPEC BUS & CSO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,881 F1 · shares: Shares surrendered by reporting person to satisfy withholding tax obligation upon vesting of restricted stock granted on February 27, 2017 under the Company's 2016 Long-Term Performance Incentive Plan. Read SEC document |
| August 15, 2019 Filed Aug 19, 2019 20:29 UTC | QUAKER CHEMICAL CORP KWR · Entity 4278 | GrantEmployee Stock Option (right to buy) · Derivative | 2,526 | $0.00 Strike: $154.92 | $0.00 |
DisclosureSEC source: 0001209191-19-046547 · doc4.xml · derivative · entry 4 BERQUIST JOSEPH A · CIK 0001487224 · SVP, GL SPEC BUS & CSO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,526 Underlying: Common Stock · 2,526 shares Expires 2026-02-25 F2 · derivative.exercise_date: This award represents time-based restricted stock and stock options granted to reporting person for the 2019-2021 Performance Period under the Company's 2016 Long-Term Performance Incentive Plan. The restricted stock vests on February 25, 2022 and the stock options are exercisable in three consecutive annual installments: 842 shares on February 25, 2020; 842 shares on February 25, 2021; and 842 shares on February 25, 2022. Read SEC document |
| August 15, 2019 Filed Aug 19, 2019 20:29 UTC | QUAKER CHEMICAL CORP KWR · Entity 4278 | GrantCommon Stock | 516 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-046547 · doc4.xml · nonDerivative · entry 2 BERQUIST JOSEPH A · CIK 0001487224 · SVP, GL SPEC BUS & CSO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,041 F2 · shares: This award represents time-based restricted stock and stock options granted to reporting person for the 2019-2021 Performance Period under the Company's 2016 Long-Term Performance Incentive Plan. The restricted stock vests on February 25, 2022 and the stock options are exercisable in three consecutive annual installments: 842 shares on February 25, 2020; 842 shares on February 25, 2021; and 842 shares on February 25, 2022. Read SEC document |
| August 15, 2019 Filed Aug 19, 2019 20:29 UTC | QUAKER CHEMICAL CORP KWR · Entity 4278 | GrantCommon Stock | 1,936 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-046547 · doc4.xml · nonDerivative · entry 1 BERQUIST JOSEPH A · CIK 0001487224 · SVP, GL SPEC BUS & CSO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,525 F1 · shares: This award represents a one-time, time-based restricted stock award granted in recognition of the reporting person's efforts to close the combination between Quaker Chemical Corporation and Houghton International. The restricted stock vests on August 1, 2022. Read SEC document |
| February 23, 2019 Filed Feb 26, 2019 21:18 UTC | QUAKER CHEMICAL CORP KWR · Entity 4278 | Tax withholdingCommon Stock | 322 | $212.05 | $68,280.10 |
DisclosureSEC source: 0001209191-19-013502 · doc4.xml · nonDerivative · entry 1 BERQUIST JOSEPH A · CIK 0001487224 · VP & Managing Director - NA 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,589 F1 · shares: Shares surrendered by reporting person to satisfy withholding tax obligation upon vesting of restricted stock granted on February 23, 2016 under the Company's 2011 Long-Term Performance Incentive Plan. Read SEC document |
| December 03, 2018 Filed Dec 6, 2018 21:10 UTC | QUAKER CHEMICAL CORP KWR · Entity 4278 | SaleCommon Stock | 266 | $210.00 | $55,860.00 |
DisclosureSEC source: 0001209191-18-061236 · doc4.xml · nonDerivative · entry 1 BERQUIST JOSEPH A · CIK 0001487224 · VP & Managing Director - NA 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,911 F1 · kind: The sale of shares reported for this transaction was effected pursuant to a Rule 10b5-1 Plan entered into by reporting person on May 16, 2018. Read SEC document |
| November 02, 2018 Filed Nov 6, 2018 21:22 UTC | QUAKER CHEMICAL CORP KWR · Entity 4278 | SaleCommon Stock | 234 | $210.50 | $49,257.00 |
DisclosureSEC source: 0001209191-18-057388 · doc4.xml · nonDerivative · entry 1 BERQUIST JOSEPH A · CIK 0001487224 · VP & Managing Director - NA 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,177 F1 · kind: The sale of shares reported for this transaction was effected pursuant to a Rule 10b5-1 Plan entered into by reporting person on May 16, 2018. Read SEC document |
| September 11, 2018 Filed Sep 13, 2018 20:17 UTC | QUAKER CHEMICAL CORP KWR · Entity 4278 | SaleCommon Stock | 1,000 | $190.64 | $190,641.00 |
DisclosureSEC source: 0001209191-18-050840 · doc4.xml · nonDerivative · entry 1 BERQUIST JOSEPH A · CIK 0001487224 · VP & Managing Director - NA 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,411 F1 · kind: The sale of shares reported for this transaction was effected pursuant to a Rule 10b5-1 Plan entered into by reporting person on May 16, 2018. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $190.60 to $191.00, inclusive. The reporting person undertakes to provide to Quaker Chemical Corporation ("Quaker"), any security holder of Quaker, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4. Read SEC document |
| July 31, 2018 Filed Aug 2, 2018 20:14 UTC | QUAKER CHEMICAL CORP KWR · Entity 4278 | SaleCommon Stock | 500 | $170.84 | $85,419.00 |
DisclosureSEC source: 0001209191-18-044942 · doc4.xml · nonDerivative · entry 1 BERQUIST JOSEPH A · CIK 0001487224 · VP & Managing Director - NA 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,411 F1 · kind: The sale of shares reported for this transaction was effected pursuant to a Rule 10b5-1 Plan entered into by reporting person on May 16, 2018. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $170.75 to $170.98, inclusive. The reporting person undertakes to provide to Quaker Chemical Corporation ("Quaker"), any security holder of Quaker, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4. Read SEC document |
| May 04, 2018 Filed May 8, 2018 20:22 UTC | QUAKER CHEMICAL CORP KWR · Entity 4278 | SaleCommon Stock | 2,000 | $147.00 | $294,000.60 |
DisclosureSEC source: 0001209191-18-028578 · doc4.xml · nonDerivative · entry 1 BERQUIST JOSEPH A · CIK 0001487224 · VP & Managing Director - NA 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,911 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $147.00 to $147.20, inclusive. The reporting person undertakes to provide to Quaker Chemical Corporation ("Quaker"), any security holder of Quaker, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) to this Form 4. Read SEC document |
| March 09, 2018 Filed Mar 12, 2018 20:35 UTC | QUAKER CHEMICAL CORP KWR · Entity 4278 | OtherCommon Stock | 1,290 | $157.99 | $203,807.10 |
DisclosureSEC source: 0001209191-18-018874 · doc4.xml · nonDerivative · entry 6 BERQUIST JOSEPH A · CIK 0001487224 · VP & Managing Director - NA 10b5-1 filing: Not disclosed Ownership: Indirect · By 401(k) Disclosed balance after: 1,564 F4 · balance_after: Based on account information as of March 9, 2018 and obtained by reporting person from Plan Administrator. Read SEC document |
| March 08, 2018 Filed Mar 12, 2018 20:35 UTC | QUAKER CHEMICAL CORP KWR · Entity 4278 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 1,213 | $0.00 Strike: $72.12 | $0.00 |
DisclosureSEC source: 0001209191-18-018874 · doc4.xml · derivative · entry 8 BERQUIST JOSEPH A · CIK 0001487224 · VP & Managing Director - NA 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,213 Underlying: Common Stock · 1,213 shares Expires 2023-02-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_date: The options for this grant vest in three annual installments: 1,213 shares on February 23, 2017; 1,213 shares on February 23, 2018; and 1,213 shares on February 23, 2019. Read SEC document |
| March 08, 2018 Filed Mar 12, 2018 20:35 UTC | QUAKER CHEMICAL CORP KWR · Entity 4278 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 744 | $0.00 Strike: $87.30 | $0.00 |
DisclosureSEC source: 0001209191-18-018874 · doc4.xml · derivative · entry 7 BERQUIST JOSEPH A · CIK 0001487224 · VP & Managing Director - NA 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 744 shares Expires 2022-02-25 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: The options for this grant vested in three annual installments: 745 shares on February 25, 2016; 744 shares on February 25, 2017; and 744 shares on February 25, 2018. Read SEC document |
| March 08, 2018 Filed Mar 12, 2018 20:35 UTC | QUAKER CHEMICAL CORP KWR · Entity 4278 | SaleCommon Stock | 58 | $152.74 | $8,858.92 |
DisclosureSEC source: 0001209191-18-018874 · doc4.xml · nonDerivative · entry 5 BERQUIST JOSEPH A · CIK 0001487224 · VP & Managing Director - NA 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,911 F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $152.49 to $152.75, inclusive. The reporting person undertakes to provide to Quaker Chemical Corporation ("Quaker"), any security holder of Quaker, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (3) to this Form 4. Read SEC document |
| March 08, 2018 Filed Mar 12, 2018 20:35 UTC | QUAKER CHEMICAL CORP KWR · Entity 4278 | SaleCommon Stock | 1,155 | $152.06 | $175,623.64 |
DisclosureSEC source: 0001209191-18-018874 · doc4.xml · nonDerivative · entry 4 BERQUIST JOSEPH A · CIK 0001487224 · VP & Managing Director - NA 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,969 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $151.485 to $152.48, inclusive. The reporting person undertakes to provide to Quaker Chemical Corporation ("Quaker"), any security holder of Quaker, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4. Read SEC document |
| March 08, 2018 Filed Mar 12, 2018 20:35 UTC | QUAKER CHEMICAL CORP KWR · Entity 4278 | Exercise / conversionCommon Stock | 1,213 | $72.12 | $87,481.56 |
DisclosureSEC source: 0001209191-18-018874 · doc4.xml · nonDerivative · entry 3 BERQUIST JOSEPH A · CIK 0001487224 · VP & Managing Director - NA 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,124 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 08, 2018 Filed Mar 12, 2018 20:35 UTC | QUAKER CHEMICAL CORP KWR · Entity 4278 | SaleCommon Stock | 744 | $152.93 | $113,777.17 |
DisclosureSEC source: 0001209191-18-018874 · doc4.xml · nonDerivative · entry 2 BERQUIST JOSEPH A · CIK 0001487224 · VP & Managing Director - NA 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,911 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $152.75 to $153.355, inclusive. The reporting person undertakes to provide to Quaker Chemical Corporation ("Quaker"), any security holder of Quaker, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) to this Form 4. Read SEC document |
| March 08, 2018 Filed Mar 12, 2018 20:35 UTC | QUAKER CHEMICAL CORP KWR · Entity 4278 | Exercise / conversionCommon Stock | 744 | $87.30 | $64,951.20 |
DisclosureSEC source: 0001209191-18-018874 · doc4.xml · nonDerivative · entry 1 BERQUIST JOSEPH A · CIK 0001487224 · VP & Managing Director - NA 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,655 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 05, 2018 Filed Mar 6, 2018 21:16 UTC | QUAKER CHEMICAL CORP KWR · Entity 4278 | Tax withholdingCommon Stock | 569 | $150.18 | $85,452.42 |
DisclosureSEC source: 0001209191-18-017215 · doc4.xml · nonDerivative · entry 1 BERQUIST JOSEPH A · CIK 0001487224 · VP & Managing Director - NA 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,911 F1 · shares: Shares surrendered by reporting person to satisfy withholding tax obligation upon vesting of restricted stock granted on March 5, 2013 under the Company's 2011 Long-Term Performance Incentive Plan. Read SEC document |
| February 26, 2018 Filed Feb 27, 2018 22:10 UTC | QUAKER CHEMICAL CORP KWR · Entity 4278 | GrantEmployee Stock Option (right to buy) · Derivative | 2,490 | $0.00 Strike: $151.75 | $0.00 |
DisclosureSEC source: 0001209191-18-014000 · doc4.xml · derivative · entry 5 BERQUIST JOSEPH A · CIK 0001487224 · VP & Managing Director - NA 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,490 Underlying: Common Stock · 2,490 shares Expires 2025-02-26 F3 · derivative.exercise_date: Stock options granted to reporting person under the Company's 2016 Long-Term Performance Incentive Plan and exercisable in three consecutive annual installments: 830 shares on February 26, 2019; 830 shares on February 26, 2020; and 830 shares on February 26, 2021. Read SEC document |
| February 26, 2018 Filed Feb 27, 2018 22:10 UTC | QUAKER CHEMICAL CORP KWR · Entity 4278 | GrantCommon Stock | 132 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-014000 · doc4.xml · nonDerivative · entry 3 BERQUIST JOSEPH A · CIK 0001487224 · VP & Managing Director - NA 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,480 Read SEC document |
| February 26, 2018 Filed Feb 27, 2018 22:10 UTC | QUAKER CHEMICAL CORP KWR · Entity 4278 | GrantCommon Stock | 373 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-014000 · doc4.xml · nonDerivative · entry 2 BERQUIST JOSEPH A · CIK 0001487224 · VP & Managing Director - NA 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,348 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.